Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study

✍ Scribed by D. A. TREGOUET; R. SCHNABEL; M. C. ALESSI; T. GODEFROY; P. J. DECLERCK; V. NICAUD; T. MUNZEL; C. BICKEL; H. J. RUPPRECHT; E. LUBOS; T. ZELLER; I. JUHAN-VAGUE; S. BLANKENBERG; L. TIRET; P. E. MORANGE; FOR THE ATHEROGENE INVESTIGATORS

• Book ID: 109152779
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 212 KB
• Volume: 7
• Category: Article
• ISSN: 1538-7933
• DOI: 10.1111/j.1538-7836.2008.03221.x